Posters On Demand

Dr. Brazzell is currently Chief Medical Officer for Kala Pharmaceuticals. He has more than 25 years of experience in the ophthalmic pharmaceutical industry, holding key management positions at several ophthalmic companies. In addition to Kala, Dr. Brazzell also serves as CMO for Mimetogen Pharmaceuticals. Previously he held key executive positions at Inspire Pharmaceuticals, including Executive Vice President of Medical and Scientific Affairs and Executive Vice President and Head of Ophthalmology Business. Prior to joining Inspire, he served as Global Head of Clinical R&D and Senior Vice President, U.S. R&D, for Novartis Ophthalmics. In addition to managing the global clinical R&D group for Novartis Ophthalmics, Dr. Brazzell built and managed the U.S.-based R&D group for Ciba Vision Ophthalmics, while serving as their Vice President, R&D, and served as Associate Director, R&D, at Alcon Laboratories, Inc. Dr. Brazzell received a B.S. in Pharmacy and a Ph.D. in Pharmaceutical Sciences from the University of Kentucky.